Αναζήτηση Δραστικών

DOBUTAMINE

Εμπορικές Ονομασίες

  • DOBUTAN
    Μορφές: SOL.INF
    Μορφές: C/S.SOL.IN
  • DRUGBANK - Dobutamine
  • indication:

    For inotropic support in the short- term treatment of patients with cardiac decompensation due to depressed contractility resulting either from organic heart disease or from cardiac surgical procedures

  • pharmacology:

  • mechanism:

    Dobutamine directly stimulates beta-1 receptors of the heart to increase myocardial contractility and stroke volume, resulting in increased cardiac output.

  • toxicity:

  • absorprion:

  • halflife:

    2 minutes

  • roouteelimination:

    In human urine, the major excretion products are the conjugates of dobutamine and 3-O-methyl dobutamine.

  • volumedistribution:

  • clearance: